Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths | Zendy

Mehmet Burcu | Zendy; Julie M. Zito | Zendy; Daniel J. Safer | Zendy; Laurence S. Magder | Zendy; Susan dosReis | Zendy; Fadia T. Shaya | Zendy; Geoffrey L. Rosenthal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths

Author(s) -

Mehmet Burcu,

Julie M. Zito,

Daniel J. Safer,

Laurence S. Magder,

Susan dosReis,

Fadia T. Shaya,

Geoffrey L. Rosenthal

Publication year - 2017

Publication title -

jama pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.004

H-Index - 183

eISSN - 2168-6211

pISSN - 2168-6203

DOI - 10.1001/jamapediatrics.2017.2896

Subject(s) - medicine , antidepressant , medicaid , retrospective cohort study , type 2 diabetes , cohort , cohort study , diabetes mellitus , psychiatry , pediatrics , endocrinology , health care , hippocampus , economics , economic growth

Antidepressants are one of the most commonly prescribed classes of psychotropic medications among US youths. For adults, there is emerging evidence on the increased risk of type 2 diabetes in association with antidepressant use. However, little is known about the antidepressant treatment-emergent risk of type 2 diabetes among youths.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research